These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31629115)

  • 1. Co-activation of selective nicotinic acetylcholine receptors is required to reverse beta amyloid-induced Ca
    Sun JL; Stokoe SA; Roberts JP; Sathler MF; Nip KA; Shou J; Ko K; Tsunoda S; Kim S
    Neurobiol Aging; 2019 Dec; 84():166-177. PubMed ID: 31629115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
    Roberts JP; Stokoe SA; Sathler MF; Nichols RA; Kim S
    J Biol Chem; 2021; 296():100402. PubMed ID: 33571523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-activation of selective nicotinic acetylcholine receptor subtypes is required to reverse hippocampal network dysfunction and prevent fear memory loss in Alzheimer's disease.
    Lee R; Kim G; Kim S
    bioRxiv; 2024 Oct; ():. PubMed ID: 39026693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Abeta1-42M35C mutated amyloid peptide Abeta1-42 and the 25-35 fragment fail to mimic the subtype-specificity of actions on recombinant human nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4).
    Pym LJ; Buckingham SD; Tsetlin V; Boyd CA; Sattelle DB
    Neurosci Lett; 2007 Oct; 427(1):28-33. PubMed ID: 17945421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel nicotinic mechanism underlies β-amyloid-induced neuronal hyperexcitation.
    Liu Q; Xie X; Lukas RJ; St John PA; Wu J
    J Neurosci; 2013 Apr; 33(17):7253-63. PubMed ID: 23616534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
    J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.
    Oz M; Lorke DE; Yang KH; Petroianu G
    Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by beta-amyloid1-42 peptide.
    Lamb PW; Melton MA; Yakel JL
    J Mol Neurosci; 2005; 27(1):13-21. PubMed ID: 16055943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of sustained exposure to β-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptors.
    Arora K; Alfulaij N; Higa JK; Panee J; Nichols RA
    J Biol Chem; 2013 Apr; 288(16):11175-90. PubMed ID: 23479730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
    Dineley KT; Westerman M; Bui D; Bell K; Ashe KH; Sweatt JD
    J Neurosci; 2001 Jun; 21(12):4125-33. PubMed ID: 11404397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
    D'Andrea MR; Nagele RG
    Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α7 Nicotinic acetylcholine receptor-specific antibody induces inflammation and amyloid β42 accumulation in the mouse brain to impair memory.
    Lykhmus O; Voytenko L; Koval L; Mykhalskiy S; Kholin V; Peschana K; Zouridakis M; Tzartos S; Komisarenko S; Skok M
    PLoS One; 2015; 10(3):e0122706. PubMed ID: 25816313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q; Xie X; Emadi S; Sierks MR; Wu J
    Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
    Hernandez CM; Dineley KT
    Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus.
    Mura E; Zappettini S; Preda S; Biundo F; Lanni C; Grilli M; Cavallero A; Olivero G; Salamone A; Govoni S; Marchi M
    PLoS One; 2012; 7(1):e29661. PubMed ID: 22253754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
    Wu MN; He YX; Guo F; Qi JS
    Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.